The Government of Vietnam has officially promulgated Decree No. 192/2026/NĐ-CP, regulating specific allowance regimes within the healthcare sector and monthly... Read more
Category: Uncategorized
Kotrans fined 147.5 million VND and ordered to remediate 8 non-compliant cosmetic products
The Drug Administration of Vietnam, operating under the Ministry of Health, has issued an official administrative sanction decree targeting Kotrans... Read more
DAV fines Kotrans nearly 600 million VND, orders destruction of 4 cosmetic products
The Drug Administration of Vietnam (DAV), operating under the Ministry of Health, has issued an official administrative sanction decision targeting... Read more
Australia issues urgent recall for two Nature’s Own supplements and Allen’s gummy candy over foreign matter contamination
Regulatory authorities in Australia have issued concurrent urgent safety recall notices targeting two widely distributed dietary supplement variants under the... Read more
Travere licenses Everest Medicines’ kidney drug in a strategic alliance valued up to $1.14 billion
Biopharmaceutical developer Travere Therapeutics has entered into a definitive global licensing covenant with biotechnology firm Everest Medicines to collaboratively develop... Read more
US announces re-engagement with Gavi vaccine alliance amid worsening African Ebola outbreak
WASHINGTON/LONDON (Reuters) — U.S. Secretary of State Marco Rubio has formally announced that the United States will resume its operational... Read more
FDA accepts Roche’s NDA for early-stage breast cancer therapy giredestrant under Priority Review
The United States Food and Drug Administration (FDA) has formally accepted Roche's New Drug Application (NDA) and granted Priority Review... Read more
Merck trims New Jersey headcount by 88 as part of a $3 billion global restructuring plan
U.S. pharmaceutical titan Merck & Co. has initiated the next phase of its ongoing corporate reorganization, cutting 88 positions at... Read more
Western pharma giants’ billion-dollar investments in China trigger intense regulatory backlash in the US
International financial and medical registries have logged a major wave of capital reallocation as dominant U.S. and European pharmaceutical conglomerates... Read more








